Trichomonas vaginalis contact-dependent cytolysis of epithelial cells

Infection and Immunity

Volumn 81, Issue 5, 2013, Pages 1411-1419

  Lustig, Gila ^a   Ryan, Christopher M ^a   Secor, W Evan ^b   Johnson, Patricia J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FEMALE; HEMOLYSIS; HOST CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; TRICHOMONAS VAGINALIS; UTERINE CERVIX EPITHELIUM;

CELL ADHESION; CELL LINE; EPITHELIAL CELLS; FEMALE; HEMOLYSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; PROSTATE; TRICHOMONAS VAGINALIS; VAGINA;

EID: 84877830005     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01244-12     Document Type: Article

References (76)

1. Rowley R, Toskin I, Ndowa F. 2012. Global incidence and prevalence of selected curable sexually transmitted infections-2008. 978 92 4 150383 9. WHO, Geneva, Switzerland.
2. Borchardt KA, al-Haraci S, Maida N. 1995. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin. Med. 71:405- 406.
3. Schwebke JR, Hook EW, III. 2003. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J. Infect. Dis. 188:465- 468.
4. Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS. 2007. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin. Infect. Dis. 44:13-22.
5. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. 2003. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex. Transm. Infect. 79:151-153.
6. Krieger JN, Verdon M, Siegel N, Holmes KK. 1993. Natural history of urogenital trichomoniasis in men. J. Urol. 149:1455-1458.
7. Schmid GS, Rowley J. 2011. Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. 978 92 4 150245 0. WHO, Geneva, Switzerland.
8. Fouts AC, Kraus SJ. 1980. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis. 141:137-143.
9. Krieger JN. 1995. Trichomoniasis in men: old issues and new data. Sex. Transm. Dis. 22:83-96.
10. Cotch MF, Pastorek JG, II, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex. Transm. Dis. 24:353-360.
11. Petrin D, Delgaty K, Bhatt R, Garber G. 1998. Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Microbiol. Rev. 11:300- 317.
12. Soper D. 2004. Trichomoniasis: under control or undercontrolled? Am. J. Obstet. Gynecol. 190:281-290.
13. Grodstein F, Goldman MB, Cramer DW. 1993. Relation of tubal infertility to history of sexually transmitted diseases. Am. J. Epidemiol. 137: 577-584.
14. Lloyd GL, Case JR, De Frias D, Brannigan RE. 2003. Trichomonas vaginalis orchitis with associated severe oligoasthenoteratospermia and hypogonadism. J. Urol. 170:924.
15. Misra JS, Das K, Chandrawati. 1998. Results of clinically downstaging cervical cancer in a cytological screening programme. Diagn. Cytopathol. 19:344 -348.
16. Sayed el-Ahl SA, el-Wakil HS, Kamel NM, Mahmoud MS. 2002. A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women. J. Egypt Soc. Parasitol. 32:167-178.
17. Zhang ZF, Begg CB. 1994. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol. 23:682- 690.
18. Zhang ZF, Graham S, Yu SZ, Marshall J, Zielezny M, Chen YX, Sun M, Tang SL, Liao CS, Xu JL, et al. 1995. Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann. Epidemiol. 5:325-332.
19. Mitteregger D, Aberle SW, Makristathis A, Walochnik J, Brozek W, Marberger M, Kramer G. 2012. High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue. Med. Microbiol. Immunol. 201:113-116.
20. Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA. 2009. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J. Natl. Cancer Inst. 101:1406 -1411.
21. Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, Zenilman JM, De Marzo AM, Platz EA. 2009. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Int. J. Cancer 124:2082-2087.
22. Sutcliffe S, Giovannucci E, Alderete JF, Chang TH, Gaydos CA, Zenilman JM, De Marzo AM, Willett WC, Platz EA. 2006. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15:939 -945.
23. McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM. 2007. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J. Infect. Dis. 195: 698-702.
24. Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS. 2008. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J. Infect. Dis. 197:548 -554.
25. Wasserheit JN. 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19:61-77.
26. Mason PR, Fiori PL, Cappuccinelli P, Rappelli P, Gregson S. 2005. Seroepidemiology of Trichomonas vaginalis in rural women in Zimbabwe and patterns of association with HIV infection. Epidemiol. Infect. 133: 315-323.
27. Mavedzenge SN, Pol BV, Cheng H, Montgomery ET, Blanchard K, de Bruyn G, Ramjee G, Straten A. 2010. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex. Transm. Dis. 37:460-466.
28. Kulda J, Vojtechovska M, Tachezy J, Demes P, Kunzova E. 1982. Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis-a case report. Br. J. Vener. Dis. 58:394 -399.
29. Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. 2001. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J. Reprod. Med. 46:545-549.
30. Workowski KA, Berman SM. 2006. Sexually transmitted diseases treatment guidelines, 2006. MMWR. Recommend. Rep. 55:1-94.
31. Ryan CM, de Miguel N, Johnson PJ. 2011. Trichomonas vaginalis: current understanding of host-parasite interactions. Essays Biochem. 51:161- 175.
32. Okumura CY, Baum LG, Johnson PJ. 2008. Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis. Cell. Microbiol. 10:2078 -2090.
33. Ryan CM, Mehlert A, Richardson JM, Ferguson MA, Johnson PJ. 2011. Chemical structure of Trichomonas vaginalis surface lipoglycan: a role for short galactose (beta1-4/3) N-acetylglucosamine repeats in host cell interaction. J. Biol. Chem. 286:40494-40508.
34. Bastida-Corcuera FD, Okumura CY, Colocoussi A, Johnson PJ. 2005. Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells. Eukaryot. Cell 4:1951- 1958.
35. de Miguel N, Lustig G, Twu O, Chattopadhyay A, Wohlschlegel JA, Johnson PJ. 2010. Proteome analysis of the surface of Trichomonas vaginalis reveals novel proteins and strain-dependent differential expression. Mol. Cell. Proteomics 9:1554 -1566.
36. Hirt RP, de Miguel N, Nakjang S, Dessi D, Liu YC, Diaz N, Rappelli P, Acosta-Serrano A, Fiori PL, Mottram JC. 2011. Trichomonas vaginalis pathobiology new insights from the genome sequence. Adv. Parasitol. 77:87-140.
37. Noel CJ, Diaz N, Sicheritz-Ponten T, Safarikova L, Tachezy J, Tang P, Fiori PL, Hirt RP. 2010. Trichomonas vaginalis vast BspA-like gene family: evidence for functional diversity from structural organisation and transcriptomics. BMC Genomics 11:99.
38. Christian RT, Miller NF, Ludovici PP, Riley GM. 1963. A study of Trichomonas vaginalis in human cell culture. Am. J. Obstet. Gynecol. 85: 947-954.
39. Fiori PL, Rappelli P, Addis MF, Mannu F, Cappuccinelli P. 1997. Contact-dependent disruption of the host cell membrane skeleton induced by Trichomonas vaginalis. Infect. Immun. 65:5142-5148.
40. Fiori PL, Rappelli P, Addis MF, Sechi A, Cappuccinelli P. 1996. Trichomonas vaginalis haemolysis: pH regulates a contact-independent mechanism based on pore-forming proteins. Microb. Pathog. 20:109- 118.
41. Krieger JN, Ravdin JI, Rein MF. 1985. Contact-dependent cytopathogenic mechanisms of Trichomonas vaginalis. Infect. Immun. 50:778 -786.
42. Pindak FF, Mora de Pindak M, Gardner WA, Jr. 1993. Contactindependent cytotoxicity of Trichomonas vaginalis. Genitourin. Med. 69: 35-40.
43. Fichorova RN, Rheinwald JG, Anderson DJ. 1997. Generation of papillomavirus- immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissuespecific differentiation proteins. Biol. Reprod. 57:847- 855.
44. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. 1995. Establishment and characterization of an immortalized but nontransformed human prostate epithelial cell line: BPH-1. In Vitro Cell. Dev. Biol. Animal 31:14 -24.
45. Krieger JN, Poisson MA, Rein MF. 1983. Beta-hemolytic activity of Trichomonas vaginalis correlates with virulence. Infect. Immun. 41:1291- 1295.
46. Clark CG, Diamond LS. 2002. Methods for cultivation of luminal parasitic protists of clinical importance. Clin. Microbiol. Rev. 15:329 -341.
47. Cohen J. 2003. Applied multiple regression/correlation analysis for the behavioral sciences, 3rd ed. L. Erlbaum Associates, Mahwah, NJ.
48. Harris DI, Beechey RB, Linstead D, Barrett J. 1988. Nucleoside uptake by Trichomonas vaginalis. Mol. Biochem. Parasitol. 29:105-116.
49. Peterson KM, Alderete JF. 1984. Selective acquisition of plasma proteins by Trichomonas vaginalis and human lipoproteins as a growth requirement for this species. Mol. Biochem. Parasitol. 12:37- 48.
50. Ter Kuile BH. 1994. Adaptation of the carbon metabolism of Trichomonas vaginalis to the nature and availability of the carbon source. Microbiology 140:2503-2510.
51. Zuo X, Lockwood BC, Coombs GH. 1995. Uptake of amino acids by the parasitic, flagellated protist Trichomonas vaginalis. Microbiology 141: 2637-2642.
52. Bopp SK, Lettieri T. 2008. Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line. BMC Pharmacol. 8:8.
53. Kendig DM, Tarloff JB. 2007. Inactivation of lactate dehydrogenase by several chemicals: implications for in vitro toxicology studies. Toxicol. In Vitro 21:125-132.
54. Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Liron Y, Rosenfeld N, Danon T, Perzov N, Alon U. 2006. Variability and memory of protein levels in human cells. Nature 444:643- 646.
55. Fiori PL, Rappelli P, Rocchigiani AM, Cappuccinelli P. 1993. Trichomonas vaginalis haemolysis: evidence of functional pores formation on red cell membranes. FEMS Microbiol. Lett. 109:13-18.
56. Krieger JN, Wolner-Hanssen P, Stevens C, Holmes KK. 1990. Characteristics of Trichomonas vaginalis isolates from women with and without colpitis macularis. J. Infect. Dis. 161:307-311.
57. Honigberg BM. 1961. Comparative pathogenicity of Trichomonas vaginalis and Trichomonas gallinae to mice. I. Gross pathology, quantitative evaluation of virulence, and some factors affecting pathogenicity. J. Parasitol. 47:545-571.
58. Kuczynska K, Choromanski L, Honigberg BM. 1984. Comparison of virulence of clones of two Trichomonas vaginalis strains by the subcutaneous mouse assay. Z Parasitenkd. 70:141-146.
59. Reardon LV, Ashburn LL, Jacobs L. 1961. Differences in strains of Trichomonas vaginalis as revealed by intraperitoneal injections into mice. J. Parasitol. 47:527-532.
60. Warton A, Honigberg BM. 1980. Lectin analysis of surface saccharides in two Trichomonas vaginalis strains differing in pathogenicity. J. Protozool. 27:410-419.
61. Warton A, Honigberg BM. 1983. Analysis of surface saccharides in Trichomonas vaginalis strains with various pathogenicity levels by fluorescein- conjugated plant lectins. Z Parasitenkd. 69:149 -159.
62. Drummond AC. 1936. Trichomonas infestation of the prostate gland. Am. J. Surg. 31:98 -103.
63. Honigberg BM. 1990. Trichomonads parasitic in humans. Springer- Verlag, New York, NY.
64. Swygard H, Sena AC, Hobbs MM, Cohen MS. 2004. Trichomoniasis: clinical manifestations, diagnosis and management. Sex. Transm. Infect. 80:91-95.
65. Fiori PL, Rappelli P, Addis MF. 1999. The flagellated parasite Trichomonas vaginalis: new insights into cytopathogenicity mechanisms. Microbes Infect. 1:149 -156.
66. Tabibzadeh S. 1996. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol. Hum. Reprod. 2:77-92.
67. Wolf DP, Sokoloski JE, Litt M. 1980. Composition and function of human cervical mucus. Biochim. Biophys. Acta 630:545-558.
68. Spinillo A, Bernuzzi AM, Cevini C, Gulminetti R, Luzi S, De Santolo A. 1997. The relationship of bacterial vaginosis, Candida and Trichomonas infection to symptomatic vaginitis in postmenopausal women attending a vaginitis clinic. Maturitas 27:253-260.
69. Upcroft JA, Upcroft P. 2001. Drug susceptibility testing of anaerobic protozoa. Antimicrob. Agents Chemother. 45:1810 -1814.
70. Hollander DH, Tysor JS. 1987. Isolation of a stable clone of the ameboidadherent (AA) variant of Trichomonas vaginalis. J. Parasitol. 73:1074- 1075.
71. Muller M, Lossick JG, Gorrell TE. 1988. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15:17-24.
72. Van den Bossche H (ed). 1976. Biochemistry of parasites and hostparasite relationships: proceedings of the second International Symposium on the Biochemistry of Parasites and Host-Parasite Relationships, Beerse, Belgium, 28 June-1 July, 1976. North Holland Publishing Co., New York, NY.
73. Goldman LM, Upcroft JA, Workowski K, Rapkin A. 2009. Treatment of metronidazole-resistant Trichomonas vaginalis. Sex. Health 6: 345-347.
74. Muller M, Meingassner JG, Miller WA, Ledger WJ. 1980. Three metronidazole- resistant strains of Trichomonas vaginalis from the United States. Am. J. Obstet. Gynecol. 138:808-812.
75. Lossick JG, Muller M, Gorrell TE. 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. 153:948 -955.
76. Tai JH, Su HM, Tsai J, Shaio MF, Wang CC. 1993. The divergence of Trichomonas vaginalis virus RNAs among various isolates of Trichomonas vaginalis. Exp. Parasitol. 76:278 -286.